Initiation of the gonadotropin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is >14 mm

被引：7

作者：

Klipstein, S

Reindollar, RH

Regan, MM

Alper, MM

机构：

[1] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

来源：

FERTILITY AND STERILITY | 2004年 / 81卷 / 03期

关键词：

D O I：

10.1016/j.fertnstert.2003.07.024

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The initiation of GnRH antagonists when the lead follicle is >14 mm does not adversely affect IVF success rates and leads to a shortened duration of GnRH antagonist administration. © 2004 by American Society for Reproductive Medicine.

引用

页码：714 / 715

页数：2

Initiation of the gonadotropin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is &gt;14 mm

Initiation of the gonadotropin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is >14 mm